What is Biodesix, Inc.'s D&A?

Biodesix, Inc. (BDSX) reported D&A of $1.4M in Q1 2026.

How has Biodesix, Inc.'s D&A changed year-over-year?

Biodesix, Inc.'s D&A decreased by 3.1% year-over-year, from $1.44M to $1.4M.

What is the long-term trend for Biodesix, Inc.'s D&A?

Over 4 years (2021 to 2025), Biodesix, Inc.'s D&A has grown at a 15.6% compound annual growth rate (CAGR), from $3.18M to $5.67M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Biodesix, Inc. BDSX D&A

D&A at other companies

NeoGenomicsNEO

$8.78M-6.3%

VeracyteVCYT

$5.43M+1.3%

Adaptive BiotechnologiesADPT

$3.42M-20.7%

Personalis, Inc.PSNL

$2.37M-8.3%

Guardant HealthGH

$9.44M-7.8%

GeneDx HoldingsWGS

$6.81M+19.9%

Other financials

Income statement

See full

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

See full

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

See full

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

See full

Market cap$233.52M+476%

Enterprise value$279.56M+204%

P/S2.4×+1.9×

Profitability

See full

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

See full

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biodesix, Inc.'s D&A?: Biodesix, Inc. (BDSX) reported D&A of $1.4M in Q1 2026.
How has Biodesix, Inc.'s D&A changed year-over-year?: Biodesix, Inc.'s D&A decreased by 3.1% year-over-year, from $1.44M to $1.4M.
What is the long-term trend for Biodesix, Inc.'s D&A?: Over 4 years (2021 to 2025), Biodesix, Inc.'s D&A has grown at a 15.6% compound annual growth rate (CAGR), from $3.18M to $5.67M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.